PEGylation of recombinant hirudin in mixed aqueous–organic solutions
-
Add time:09/02/2019 Source:sciencedirect.com
Serious loss of polyethylene glycol (PEG) reagent is confronted during PEGylation of proteins in mildly acidic aqueous solution. In this study, a novel approach of PEGylation of recombinant hirudin variant-2 (HV2) with monomethoxy-PEG-succinimidyl carbonate (mPEG-SC) was developed in six mixed aqueous–organic solutions. The PEGylation efficiency in each mixed solutions was greater than that in pure aqueous solution. Structure analysis of HV2, hydrolysis kinetics of mPEG-SC, and PEGylation kinetics of HV2 in different solutions revealed that solvent effects occurred in mixed aqueous–organic solutions. According to the dominant solvent effect of PEGylation acceleration and mPEG-SC hydrolysis inhibition, the selected mixed aqueous–organic solutions could be divided into different types (PEGylation-driven, mPEG-SC hydrolysis-driven, both PEGylation and mPEG-SC hydrolysis-driven). In aqueous-DMSO solutions, the desired yield (approximately 50%) of mono-PEG-HV2 was achieved under the optimized reaction conditions. The optimal usage of PEG reagent could decrease 3–5 fold compared with that of PEGylation in pure aqueous solution. The mono-PEG-HV2 could restore its structure and bioactivity after being purified into aqueous solution. This study demonstrated that PEGylation of proteins in mixed aqueous–organic solutions could be used as an alternative method to PEGylation in pure aqueous solution.
We also recommend Trading Suppliers and Manufacturers of hirudin HV2 (cas 114265-28-0). Pls Click Website Link as below: cas 114265-28-0 suppliers
Prev:Development, validation, and clinical pharmacokinetic application of ultra-performance liquid chromatography/tandem mass spectrometry method for simultaneously determining a novel recombinant hirudin derivative (Neorudin) and its active metabolite in human serum
Next:Two-step ion-exchange chromatographic purification of recombinant hirudin-II and its C-terminal-truncated derivatives expressed in Pichia pastoris) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Regular ArticleExpression, Purification and Characterization of Multigram Amounts of a Recombinant Hybrid HV1-HV2 Hirudin Variant Expressed in Saccharomyces cerevisiae09/04/2019
- Two-step ion-exchange chromatographic purification of recombinant hirudin-II and its C-terminal-truncated derivatives expressed in Pichia pastoris09/03/2019
- Development, validation, and clinical pharmacokinetic application of ultra-performance liquid chromatography/tandem mass spectrometry method for simultaneously determining a novel recombinant hirudin derivative (Neorudin) and its active metabolite in human serum09/01/2019
- In situ PEGylation of recombinant hirudin on an anion exchange chromatography column08/31/2019
- Effects of linear and branched polyethylene glycol on PEGylation of recombinant hirudin: Reaction kinetics and in vitro and in vivo bioactivities08/30/2019
- Regular ArticlePEGylation kinetics of recombinant hirudin and its application for the production of PEGylated HV2 species08/29/2019
- Chemical modification of recombinant hirudin with palmitic acid in mixed aqueous-organic solutions08/28/2019


